LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - Erasca (NASDAQ: ERAS)

Follow NASDAQ:ERAS Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ERAS Erasca
Casdin Alexander W. / director
05/21/2024
Buy
$2.27
80,000
$182K
573,974
NASDAQ ERAS Erasca
Lim Jonathan E / director, 10 percent owner, officer: Chairman & CEO
02/05/2024
Buy
$1.70
1.50M
$2.550M
1.50M
NASDAQ ERAS Erasca
Chacko David M. / officer: CFO and CBO
02/05/2024
Buy
$1.70
600,000
$1.020M
600,000
NASDAQ ERAS Erasca
Garner Ebun / officer: General Counsel & Corp. Sec.
02/05/2024
Buy
$1.70
480,000
$816K
480,000
NASDAQ ERAS Erasca
Morris Shannon / officer: Chief Medical Officer
02/05/2024
Buy
$1.70
535,800
$911K
535,800
NASDAQ ERAS Erasca
Bristol James Arthur / director
01/01/2024
Buy
$2.13
62,747
$134K
62,747
NASDAQ ERAS Erasca
Multani Pratik S / director
01/01/2024
Buy
$2.13
32,867
$70K
32,867
NASDAQ ERAS Erasca
LIU JEAN I / director
01/01/2024
Buy
$2.13
35,482
$76K
35,482
NASDAQ ERAS Erasca
Start Valerie Denise Harding / director
01/01/2024
Buy
$2.13
39,590
$84K
39,590
NASDAQ ERAS Erasca
Casdin Alexander W. / director
01/01/2024
Buy
$2.13
41,084
$88K
41,084
NASDAQ ERAS Erasca
Chacko David M. / officer: CFO and CBO
12/15/2023
Buy
$1.59
7,478
$12K
246,726
NASDAQ ERAS Erasca
Garner Ebun / officer: General Counsel & Corp. Sec.
12/15/2023
Buy
$1.59
5,448
$9K
9,728
NASDAQ ERAS Erasca
Start Valerie Denise Harding / director
12/06/2023
Buy
$1.85
10,000
$18K
20,000
NASDAQ ERAS Erasca
Lim Jonathan E / director, 10 percent owner, officer: Chairman & CEO
12/05/2023
Buy
$1.69
721,850
$1.218M
12.90M
NASDAQ ERAS Erasca
Lim Jonathan E / director, 10 percent owner, officer: Chairman & CEO
12/06/2023
Buy
$1.72
278,150
$478K
12.90M
NASDAQ ERAS Erasca
Casdin Alexander W. / director
12/04/2023
Buy
$1.66
30,000
$50K
493,974
NASDAQ ERAS Erasca
Lim Jonathan E / director, 10 percent owner, officer: Chairman & CEO
10/05/2023
Buy
$2.03
1,000,000
$2.026M
19.46M
NASDAQ ERAS Erasca
Chen Bihua / director
06/22/2023
Buy
$2.66
60,000
$160K
60,000
NASDAQ ERAS Erasca
Varney Michael David / director
06/22/2023
Buy
$2.66
60,000
$160K
60,000
NASDAQ ERAS Erasca
Multani Pratik S / director
06/22/2023
Buy
$2.66
60,000
$160K
60,000
NASDAQ ERAS Erasca
LIU JEAN I / director
06/22/2023
Buy
$2.66
60,000
$160K
60,000
NASDAQ ERAS Erasca
Start Valerie Denise Harding / director
06/22/2023
Buy
$2.66
60,000
$160K
60,000
NASDAQ ERAS Erasca
Hambleton Julie / director
06/22/2023
Buy
$2.66
60,000
$160K
60,000
NASDAQ ERAS Erasca
Casdin Alexander W. / director
06/22/2023
Buy
$2.66
60,000
$160K
60,000
NASDAQ ERAS Erasca
Bristol James Arthur / director
06/22/2023
Buy
$2.66
60,000
$160K
60,000
NASDAQ ERAS Erasca
Lim Jonathan E / director, 10 percent owner, officer: Chairman & CEO
06/08/2023
Buy
$2.75
100,000
$275K
18.40M
NASDAQ ERAS Erasca
Morris Shannon / officer: Chief Medical Officer
04/10/2023
Buy
$2.74
375,000
$1.026M
375,000
NASDAQ ERAS Erasca
Morris Shannon / officer: Chief Medical Officer
04/10/2023
Sell
$7.91
300,000
$2.373M
0
NASDAQ ERAS Erasca
Morris Shannon / officer: Chief Medical Officer
04/10/2023
Sell
$4.00
160,800
$643K
0
NASDAQ ERAS Erasca
Casdin Alexander W. / director
04/10/2023
Buy
$2.76
20,000
$55K
463,974
NASDAQ ERAS Erasca
Lim Jonathan E / director, 10 percent owner, officer: Chairman & CEO
03/28/2023
Buy
$2.84
100,000
$284K
18.30M
NASDAQ ERAS Erasca
Lim Jonathan E / director, 10 percent owner, officer: Chairman & CEO
02/01/2023
Buy
$4.00
1.50M
$6.000M
1.50M
NASDAQ ERAS Erasca
Chacko David M. / officer: Chief Financial Officer
02/01/2023
Buy
$4.00
600,000
$2.400M
600,000
NASDAQ ERAS Erasca
Chacko David M. / officer: Chief Financial Officer
02/01/2023
Buy
$3.89
2
$8
239,248
NASDAQ ERAS Erasca
Chacko David M. / officer: Chief Financial Officer
02/01/2023
Buy
$4.10
1,748
$7K
239,248
NASDAQ ERAS Erasca
Wei Lin / officer: Chief Medical Officer
02/01/2023
Buy
$4.00
560,000
$2.240M
560,000
NASDAQ ERAS Erasca
Wei Lin / officer: Chief Medical Officer
02/01/2023
Buy
$4.10
1,748
$7K
315,812
NASDAQ ERAS Erasca
Wei Lin / officer: Chief Medical Officer
02/01/2023
Buy
$3.89
2
$8
315,812
NASDAQ ERAS Erasca
Garner Ebun / officer: General Counsel & Corp. Sec.
02/01/2023
Buy
$4.00
480,000
$1.920M
480,000
NASDAQ ERAS Erasca
Garner Ebun / officer: General Counsel & Corp. Sec.
02/01/2023
Buy
$4.10
2,388
$10K
4,280
NASDAQ ERAS Erasca
Garner Ebun / officer: General Counsel & Corp. Sec.
02/01/2023
Buy
$3.89
2
$8
4,280
NASDAQ ERAS Erasca
Lim Jonathan E / officer: Chairman & CEO
01/10/2023
Buy
$3.86
60,000
$231K
20.26M
NASDAQ ERAS Erasca
Start Valerie Denise Harding / director
12/21/2022
Buy
$4.64
10,000
$46K
10,000
NASDAQ ERAS Erasca
Bristol James Arthur / director
12/21/2022
Buy
$4.14
20,000
$83K
20,000
NASDAQ ERAS Erasca
Chen Bihua / director
12/13/2022
Buy
$6.50
307,692
$2.000M
10.81M
NASDAQ ERAS Erasca
Chen Bihua / director
12/13/2022
Buy
$6.50
307,692
$2.000M
10.81M
NASDAQ ERAS Erasca
Casdin Alexander W. / director
12/15/2022
Buy
$4.87
20,000
$97K
443,974
NASDAQ ERAS Erasca
Lim Jonathan E / officer: Chairman & CEO
12/14/2022
Buy
$4.99
40,000
$200K
20.20M
NASDAQ ERAS Erasca
Start Valerie Denise Harding / director
06/22/2022
Buy
$5.35
40,000
$214K
40,000
NASDAQ ERAS Erasca
Hambleton Julie / director
06/22/2022
Buy
$5.35
40,000
$214K
40,000
NASDAQ ERAS Erasca
Casdin Alexander W. / director
06/22/2022
Buy
$5.35
40,000
$214K
40,000

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous